Bayer Aktiengesellschaft (BAYRY) News Today

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) shares have risen today as investors respond to a new buy rating and encouraging clinical data. Key drivers include an analyst upgrade, positive trial updates and leadership stability, partly offset by mixed sports-related headlines.

• Positive Sentiment: Wall Street Zen upgraded BAYRY from “hold” to “buy,” signaling stronger analyst confidence in the company’s outlook. Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Rating Increased to Buy at Wall Street Zen
• Positive Sentiment: Bayer reported that BAY2862789 showed promising first‐in‐human safety and efficacy in early cancer trials, boosting long‐term growth prospects. Bayer’s BAY2862789: A Promising Step in Cancer Treatment
• Positive Sentiment: An observational study of darolutamide provided real‐world insights into its effectiveness and safety in prostate cancer, supporting the drug’s market potential. Bayer’s Darolutamide Study: Real-World Insights into Prostate Cancer Treatment
• Positive Sentiment: Bayer and AstraZeneca’s collaborative metastatic prostate cancer trial may be a game‐changer, combining expertise to accelerate drug development. AstraZeneca and Bayer’s Collaborative Study on Metastatic Prostate Cancer: A Potential Game-Changer?
• Positive Sentiment: The 225Ac-PSMA-Trillium Phase 1 study demonstrated Bayer’s innovative targeted alpha therapy approach, reinforcing its oncology pipeline strength. Bayer’s Innovative Approach in Prostate Cancer Treatment: A Closer Look at the 225Ac-PSMA-Trillium Study
• Positive Sentiment: Bayer extended CEO contract amid “signs of success,” affirming confidence in current leadership to drive further turnaround. Bayer extends CEO contract amid 'signs of success'
• Neutral Sentiment: A head-to-head review compared Innoviva (INVA) and Bayer, but found no clear catalyst favoring one over the other for near-term performance. Innoviva (NASDAQ:INVA) & Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Head to Head Review
• Neutral Sentiment: Bayer Leverkusen’s sporting news—interest in midfielder Granit Xhaka, friendly previews and match results—are unlikely to move the stock materially.
  • Neutral Sentiment: Bayer chief Rolfes confirmed external interest in target Granit Xhaka. Bayer chief Rolfes admits "interest" arriving for Sunderland, AC Milan target Xhaka
  • Neutral Sentiment: Chelsea vs Bayer Leverkusen friendly preview and broadcast details on DAZN. Chelsea vs Bayer Leverkusen: Club friendly preview, date, venue, how to watch on DAZN
  • Neutral Sentiment: Bayer Leverkusen’s sporting director pressed for a “win-win” transfer outcome on Xhaka. Bayer Leverkusen boss demands “win-win” scenario on Granit Xhaka transfer
  • Neutral Sentiment: Ex-United manager Erik ten Hag commented on Antony’s reunion at Leverkusen, a fan-interest story without financial impact. ‘Like a Son to Me’—Erik ten Hag Gives Verdict on Antony Reunion at Bayer Leverkusen
  • Neutral Sentiment: Flamengo U20 routed Bayer in a friendly, underscoring Leverkusen’s mixed preseason form. Flamengo under-20 steamroller Bayer Leverkusen in friendly on home soil